167 related articles for article (PubMed ID: 24038962)
1. Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.
Miodragović ĐU; Quentzel JA; Kurutz JW; Stern CL; Ahn RW; Kandela I; Mazar A; O'Halloran TV
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10749-52. PubMed ID: 24038962
[TBL] [Abstract][Full Text] [Related]
2. Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand.
Zhao J; Gou S; Liu F
Chemistry; 2014 Nov; 20(46):15216-25. PubMed ID: 25256173
[TBL] [Abstract][Full Text] [Related]
3. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J
J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.
Han J; Gao X; Liu R; Yang J; Zhang M; Mi Y; Shi Y; Gao Q
Chem Biol Drug Des; 2016 Jun; 87(6):867-77. PubMed ID: 26706102
[TBL] [Abstract][Full Text] [Related]
5. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
[TBL] [Abstract][Full Text] [Related]
6. Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.
Scaffidi-Domianello YY; Legin AA; Jakupec MA; Roller A; Kukushkin VY; Galanski MS; Keppler BK
Inorg Chem; 2012 Jul; 51(13):7153-63. PubMed ID: 22691006
[TBL] [Abstract][Full Text] [Related]
7. Anticancer platinum(II) complexes bearing N-heterocycle rings.
Facchetti G; Rimoldi I
Bioorg Med Chem Lett; 2019 Jun; 29(11):1257-1263. PubMed ID: 30935797
[TBL] [Abstract][Full Text] [Related]
8. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
9. Target-selective delivery and activation of platinum-based anticancer agents.
Ding S; Bierbach U
Future Med Chem; 2015; 7(7):911-27. PubMed ID: 26061108
[No Abstract] [Full Text] [Related]
10. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and cytotoxicity of dihalogeno-platinum(II) complexes with L-histidine ligand.
Ye QS; Xie MJ; Liu WP; Chen XZ; Yu Y; Chang QW; Hou SQ
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):424-7. PubMed ID: 19336943
[TBL] [Abstract][Full Text] [Related]
12. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
[TBL] [Abstract][Full Text] [Related]
13. Antitumor potential of platinum(II) complexes of selenium donor ligands.
Ahmad S; Isab AA; Al-Arfaj AR
Metallomics; 2023 Apr; 15(4):. PubMed ID: 36918206
[TBL] [Abstract][Full Text] [Related]
14. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
[TBL] [Abstract][Full Text] [Related]
15. Vitamin B₁₂ as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies.
Ruiz-Sánchez P; König C; Ferrari S; Alberto R
J Biol Inorg Chem; 2011 Jan; 16(1):33-44. PubMed ID: 20803225
[TBL] [Abstract][Full Text] [Related]
16. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
[TBL] [Abstract][Full Text] [Related]
18. Peptide-Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells.
Shoshan MS; Vonderach T; Hattendorf B; Wennemers H
Angew Chem Int Ed Engl; 2019 Apr; 58(15):4901-4905. PubMed ID: 30561882
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]